Literature DB >> 9764315

A cost-benefit analysis of Chagas disease control in north-western Argentina.

M A Basombrío1, C J Schofield, C L Rojas, E C del Rey.   

Abstract

Chagas disease has been controlled in the Department of Anta, Province of Salta, Argentina, through a series of vector control interventions beginning in 1983. Based on data from this programme, together with estimates of the value of benefits accruing to the programme due to avoidance of new cases of Chagas disease, we present an analysis of costs and benefits of the vector control interventions. Under all assumptions, the interventions have been highly profitable from a societal point of view, with an internal rate of return in excess of 60%. The net present value of benefits accruing to the programme is estimated to be above US$7 million.

Entities:  

Mesh:

Year:  1998        PMID: 9764315     DOI: 10.1016/s0035-9203(98)90720-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Modeling the economic value of a Chagas' disease therapeutic vaccine.

Authors:  Bruce Y Lee; Kristina M Bacon; Angela R Wateska; Maria Elena Bottazzi; Eric Dumonteil; Peter J Hotez
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.

Authors:  Bruce Y Lee; Kristina M Bacon; Diana L Connor; Alyssa M Willig; Rachel R Bailey
Journal:  PLoS Negl Trop Dis       Date:  2010-12-14

3.  Economic evaluation of environmental health interventions to support decision making.

Authors:  Guy Hutton
Journal:  Environ Health Insights       Date:  2008-12-19

4.  Control of rural house infestation by Triatoma infestans in the Bolivian Chaco using a microencapsulated insecticide formulation.

Authors:  David Eladio Gorla; Roberto Vargas Ortiz; Silvia Susana Catalá
Journal:  Parasit Vectors       Date:  2015-05-01       Impact factor: 3.876

5.  Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease.

Authors:  Edeltraud J Lenk; William K Redekop; Marianne Luyendijk; Christopher Fitzpatrick; Louis Niessen; Wilma A Stolk; Fabrizio Tediosi; Adriana J Rijnsburger; Roel Bakker; Jan A C Hontelez; Jan H Richardus; Julie Jacobson; Epke A Le Rutte; Sake J de Vlas; Johan L Severens
Journal:  PLoS Negl Trop Dis       Date:  2018-03-13

6.  Cost-effectiveness of chagas disease vector control strategies in Northwestern Argentina.

Authors:  Gonzalo M Vazquez-Prokopec; Cynthia Spillmann; Mario Zaidenberg; Uriel Kitron; Ricardo E Gürtler
Journal:  PLoS Negl Trop Dis       Date:  2009-01-20

7.  The costs of preventing and treating chagas disease in Colombia.

Authors:  Marianela Castillo-Riquelme; Felipe Guhl; Brenda Turriago; Nestor Pinto; Fernando Rosas; Mónica Flórez Martínez; Julia Fox-Rushby; Clive Davies; Diarmid Campbell-Lendrum
Journal:  PLoS Negl Trop Dis       Date:  2008-11-18

8.  Opportunity cost for early treatment of Chagas disease in Mexico.

Authors:  Janine M Ramsey; Miguel Elizondo-Cano; Gilberto Sanchez-González; Adriana Peña-Nieves; Alejandro Figueroa-Lara
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.